T80.81 Extravasation of vesicant agent

Name of the Condition

• Extravasation of vesicant agent

Summary

This condition occurs when a vesicant agent leaks from a blood vessel into surrounding tissues. Vesicants are highly irritating substances that can cause severe tissue damage when not administered properly.

Causes

Most commonly caused during intravenous (IV) administration where the agent leaks out of the vein.

Risk Factors

• High-risk factors include small veins, fragile veins often found in elderly patients, repeated cannulations, prior damage to veins from previous treatments, and inexperienced healthcare personnel administering the agent.

Symptoms

• Patients may experience pain, swelling, redness, or a burning sensation at the site of the IV injection. If severe, there might be tissue necrosis leading to ulceration.

Diagnosis

Diagnosis is primarily based on clinical examination and patient history. Imaging tests such as ultrasound might be used to assess the extent of the leakage and damage.

Treatment Options

• Immediate cessation of the infusion of the agent.
• Application of ice or heat packs, depending on the protocol for the specific agent.
• Administration of antidotes or medications to neutralize the agent.
• Surgical intervention may be required in severe cases.

Prognosis and Follow-Up

Prognosis depends on the severity of the extravasation and the promptness of treatment. Early intervention can minimize tissue damage. Follow-up care may include monitoring for infection, wound care, and pain management.

Complications

• Severe tissue damage, ulceration, infection, and potential loss of function in the affected area.

Lifestyle & Prevention

• Use of proper IV techniques, careful monitoring during administration, and training for healthcare personnel can help prevent extravasation.

When to Seek Professional Help

• Seek immediate medical attention if pain, swelling, or redness occurs at the injection site during or after administration of a vesicant agent.

Tips for Medical Coders

• Document the specific vesicant agent involved, the site of extravasation, and the clinical findings. Ensure the encounter type (e.g., initial, subsequent) is clearly recorded to support accurate coding.